Demographic breakdown of cases and controls and vaccine effectiveness by vaccination status
| Controls (n=3667) | Cases (n=1828) | % Vaccine Effectiveness (1-OR)*100 | 95% CI lower | 95% CI upper | P value | |
| Male | 1925 (52.5%) | 1159 (63.4%) | – | – | – | – |
| Female | 1742 (47.5%) | 669 (36.6%) | – | – | – | – |
| 18–39 | 1060 (28.9%) | 463 (25.3%) | – | – | – | – |
| 40–59 | 1257 (34.3%) | 800 (43.8%) | – | – | – | – |
| 60–79 | 1350 (36.8%) | 565 (30.9%) | – | – | – | – |
| Unvaccinated | 2011 (54.8%) | 1677 (91.7%) | Ref. | – | – | – |
| 1–2 doses (incomplete) | 279 (7.6%) | 75 (4.1%) | 76.8 | 69.0 | 82.6 | <0.001 |
| 3+ doses (complete) <5 years | 522 (14.2%) | 48 (2.6%) | 91.6 | 88.4 | 94.0 | <0.001 |
| 3+ doses complete 5–10 years | 397 (10.8%) | 20 (1.1%) | 95.2 | 92.4 | 97.0 | <0.001 |
| 3+ doses complete 10+ years | 458 (12.5%) | 8 (0.4%) | 98.5 | 96.8 | 99.2 | <0.001 |
| 3+ doses (complete) Any time | 1377 (37.6%) | 76 (4.2%) | 95.0 | 93.5 | 96.1 | <0.001 |